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Abstract 
 
Background: Diisocyanates are sensitizing agents that are used in many industries in the 
production of polyurethane foams, coatings and other products.  Methylene diphenyl 
diisocyanate (MDI) exposure can occur through dermal and inhalation routes resulting 
in sensitization and leading to isocyanate asthma.  MDI-specific IgG (MDI-IgG) bio-
monitoring has been proposed to be used as a predictor of exposure.  
Methods:  A prospective longitudinal study was used to assess annual MDI- IgG serum 
markers in 223 workers in a fabric-coating company. Kaplan Meir Survival Analysis 
determined whether there was a difference in seroconversion based on exposure level.  A 
Cox proportional hazard model was used to see if covariates such as total IgE level, 
cough, rash, allergies, and smoking contributed to time to change.  Data from 2012 and 
2013 were used to compare MDI-IgG level after the implementation of new safety 
measures. 
Results:  MDI- IgG seroconversion from negative to positive was statistically significant 
for a difference in the survival curves (p= 0.0076) with respect to job classification.  No 
statistical difference was found among workers for time to seroconversion from MDI-
specific IgG positive to negative (p= 0.9232).  A non-parametric sign test was used to 
evaluate the paired serology results for individuals between 2012 and 2013, indicating a 
significant decrease in MDI-specific IgG levels (p=0.0001). 
Discussion: There is a significant correlation between job classification and time to 
positive seroconversion. Biomonitoring may track and trend changes that reflect worker 
exposures.  Data suggest that safety interventions could play an important role in 
preventing MDI asthma and ensure worker safety. 
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Introduction 
Diisocyanates are potent sensitizing agents that have been identified as a 
substantial source of occupational asthma.
1-3
  The main commercial isocyanates of 
concern are methylene diphenyl diisocyanate (MDI), toluene diisocyanate (TDI), and 
hexamethylene diisocyanate (HDI).
4,5
  Monomeric and polymeric methylene diphenyl 
diisocyanate (MDI) are used to make polyurethane foams, coated fabrics  adhesives and 
other products .
6
 
The prevalence of asthma due to isocyanates is estimated to be around 5-20% of 
those with prior exposure.
7
  Workers in end-user polyurethane work settings may be at 
greater risk for developing isocyanate asthma than in primary production facilities as 
exposures in end-user settings may be harder to monitor and control.  Additionally the 
workers may be unaware of the chemical composition of the products that they are 
working with.
8
  Worker exposure can occur with various forms—vapor, aerosol,—and 
the risk of exposure can depend on factors such as temperature, mixture variability, and 
intrinsic physical properties.
4,9-11
   In recent years, MDI has been increasingly used in 
industry due to its low volatility, which decreases the risk of inhalation exposure.
4
  
Despite the development of less volatile and “safer” forms, asthma due to isocyanates 
still occurs.
8,12
  In the production of MDI fabric-coating products, the dermal and 
inhalational routes of exposure are both possible; however, skin exposures may  play a 
greater role than in spray operations where there is more opportunity for inhalational 
exposures.
13-15
  Skin exposure is difficult to quantitate, highlighting the need for MDI 
exposure biomarkers.  Few studies have monitored MDI worker exposures over 
prolonged periods of time.
5,16
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Similarities in clinical presentation and symptoms of MDI asthma suggest a 
comparable mechanism to atopic asthma (i.e. allergic immune, type I hypersensitivity 
reaction).  Generally, immune sensitization to isocyanates is presumed based on features 
such as a latency period, recurrent reactions after exposures to low concentration, and 
variable individual susceptibility.
10,17
   Once sensitized, even low levels of exposure may 
elicit an asthma response.
7,10
   
The pathogenic mechanisms to exposure and host response are poorly 
understood.
4,18
  Diisocyanates react with proteins (antibodies) and hydrolyze in solutions 
which complicates in vitro analysis.
11
  The current hypothesis of pathogenicity suggests a 
chemical reaction with self-proteins that alters their confirmation and causes the host 
immune system to recognize it as foreign.  This triggers airway inflammation and 
asthma.
11,19
  However, there may be a crucial difference in the mechanism of asthma 
induced by MDI and other allergens: antigen specific IgE responses, a hallmark of 
common atopic asthma, are often not observed in isocyanate asthmatics.
4
  
Due to uncertainties in pathogenesis, persistence away from exposure, and poor 
long-term prognosis of isocyanate asthmatics, major efforts at disease control have 
shifted to prevention.
20,21
  Exposure is the best recognized risk factor, so hygiene, 
including reduction and minimization of exposure, is considered the major strategy for 
prevention.  Exposure surveillance is crucial to ensure adequate hygiene and properly 
functioning PPE.
4,22
  
The current primary approach to surveillance of isocyanate exposure is air 
monitoring; however, problems exist with personal air sampling.
10,11
 In addition to 
missing skin exposure,  air vapor sampling may underestimate the potential inhalational 
exposures in workers due to the low volatility of MDI.
3,7
  Additionally, the cost of 
quantitative air sampling makes this approach infeasible.
3
  Previous studies have shown 
that despite negligible airborne MDI measurement, positive serum antibody markers can 
still exist.
4,23,24
 
An alternative approach to exposure surveillance is biomonitoring based on 
biomarkers of exposure.
1,25
  One such biomarker is MDI-specific IgG (MDI-IgG).
19
  MDI 
is not normally found in nature, so antibodies are not usually found in human serum.
11
  
Exposure is known to trigger IgG subclass antibodies that recognize reaction products of 
MDI attached to autologous albumin.
11,19
  Serum antibodies allow for investigation of 
exposure levels when direct measuring methods for a particular substance in the body 
does not exist.  The use of serology to biomonitor chemical exposure is a novel strategy, 
but similar sero-epidemiology is a well-established approach for following vaccine trends 
and outbreaks of infectious diseases.
11,26
      
In this study, we assessed the potential utility of MDI-specific IgG for exposure 
monitoring and evaluated the kinetics of this immunologic response among workers with 
varying levels of potential for exposure.  Participants were workers at a fabric coating 
plant, which provided prevalent opportunities for both dermal and inhalation exposure to 
MDI.  We followed the serological immunologic markers of these workers over time to 
determine whether exposure would result in seroconversion (positive MDI-IgG) and what 
risk characteristics would alter the likelihood of a person to develop immunologic 
sensitivity to MDI-Specific IgG. 
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Materials and Methods 
Overall Study Design 
The epidemiological study was designed as a prospective longitudinal study to 
assess MDI exposure among workers in a fabric-coating company.  Data were collected 
from a fabric-coating company that had previously established a contractual agreement 
for annual surveillance and physicals with Yale Occupational and Environmental 
Medicine Program (YOEMP).  Annual physicals included symptom surveillance, self-
reported questionnaires, physical exam, spirometry and blood draws for immunologic and 
other assays.  Particular to this study, serology results for total IgE and MDI-specific IgG 
as well as worker self-reported general health questionnaires were analyzed from a de-
identified database.  Informed consent was obtained from each participant and the 
protocol was approved by the Yale University Human Investigations Committee. 
Over 90% of the workers who underwent the physicals had antibody testing.  Data 
were collected for a total of 366 subjects, and 223 subjects were considered eligible for 
this analysis.  As the intention was to assess changes in antibody level and 
symptomatology over time, inclusion requirements included completion of a health 
questionnaire and existence of two or more recorded values of the studied outcome 
variable (specific IgG) between the years of 2004 and 2012.  Additionally, in order to 
determine if any differences existed in the work environment, a three-question safety 
culture survey was offered for employees to complete in 2013 regarding their personal 
perception of workplace safety within the past year.  
 
 
Questionnaire 
The subject questionnaire was self-reported and included demographic 
information and medical history.  Questions elicited concerned specific respiratory 
symptoms (e.g. shortness of breath or chest tightness), non-specific respiratory symptoms 
(e.g. cough or wheeze), temporal relationship of symptoms, occupational history, host 
factors, and use of personal protective equipment (e.g. respirator, gloves, and mask). 
MDI Exposure Assessment 
Exposure information obtained from employee questionnaires was used to assign 
each worker into one of three job categories (Table 1).  These categories were assigned 
and defined by the industrial hygienist depending on the potential for and the variability 
in length of time of exposure.  The classification scheme was constructed using previous 
air sampling and isocyanate exposure data available from historical records performed at 
the facility between 1987 and 2000.  Although the amount of production has changed, 
process changes were not determined to be so significant as to alter the exposure group 
classifications. 
Antibody studies 
Serum was analyzed for MDI-IgG by an enzyme-linked immunosorbent assay 
(ELISA), using Nunc MaxiSorp™ microtiter plates (VWR International, West Chester, 
PA) coated with 1 μg per well of albumin that was conjugated with MDI.27,28 MDI-
albumin was prepared by reacting a 5 mg*ml
-1
 solution of human albumin (Sigma 
Chemical Company, St Louis, MO), with 10% (w/v) MDI dissolved in acetone so that the 
final reaction mixture contained 0.1% (w/v) MDI.  MDI-albumin reactions were 
12 
 
performed for 2 hours at 37° C with mixing, and subsequently dialyzed against PBS 
using dialysis tubing with a 10 kDa molecular weight cut-off (MWCO).
19
   
For detection of MDI-specific human IgG from serum samples, which recognized 
any bound MDI-albumin on the ELISA plates, a peroxidase-conjugated anti-human IgG 
secondary and the substrate 3,3′,5,5′ tetramethyl benzidine were used both from 
Pharmingen (San Diego, CA).
19
  The amount of MDI-IgG present in serum samples was 
quantitated as an end-titer, which is the maximal dilution that yields a positive ELISA 
test result.  This is defined as an optical density value greater than three standard 
deviations above the mean value obtained with pooled sera of unexposed subjects (n = 
12).  An MDI-IgG titer ratio equal to or greater than 1:20 was considered significantly 
elevated based upon previously published studies with more than 1000 different 
individuals.
19,21,27,28
 
Statistical analysis 
Analysis was done using SAS v.9.2 (SAS Institute, Cary, NC).  The outcome 
variable studied was MDI-specific IgG.  Predictor variables included job classification,. 
Hispanic ethnicity, gender, age, history of asthma, previous or current smoking history, 
symptom report of shortness of breath, cough, symptoms of rash, total IgE level, 
allergies, years working at the company, and use of personal protective equipment 
(specific for gloves, mask, and respirators).  Data were collected from 2004 to 2012.   
Two different outcomes were modeled using survival analysis.  For the first set, 
time from first test until MDI-IgG changed from negative to positive was modeled.  
Interval censoring occurred in this set of data because some employees never became 
IgG-positive and others were lost to follow-up.  For the second set, the time origin was 
the date of the first positive MDI-IgG, and the event of interest was the change of MDI-
IgG from positive back to negative.  This set of data contained right-censoring due to a 
loss to follow-up and a lack of changing from positive to negative. 
To examine the time required for IgG to convert from negative to positive, as well 
as positive to negative,  Kaplan Meier Survival curves were constructed evaluated using 
the Log-Rank Test.  This analysis allows determination as to whether any of the three job 
classifications significantly differed with respect to changing IgG levels.  The assumption 
of proportional hazard was evaluated based upon a visual inspection of  
 ln(ln(survival(time))) versus ln (time) curve noting that parallel lines imply proportional 
hazards.  Cox Proportional Hazards models were conducted to determine the effect of job 
classification on changing IgG levels adjusting for covariates.  
Additionally, MDI-IgG were measured for current workers in 2012 and again in 
2013.  Since the serologic data for the workers was not normally distributed, a sign test 
was used to determine whether there was a difference in mean MDI-IgG values. 
Finally, participants were also given a three-question workplace safety survey to 
determine worker perception of safety changes in their work environment in the last year.  
These surveys were recorded on a Likert analog scale ranging from 1 through 7.  Simple 
counts and histograms were used to evaluate workplace safety interventions over the last 
year. 
Results 
Characteristics of Cohort 
The number of employees used in the study was 223 (those who fulfilled the criteria of 
completing a patient questionnaire and having more than one serology test).  The 
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majority of the population was male (87.89%) and Hispanic (56.95%) as reflective of the 
composition of the company as a whole.  An overview of the characteristics of the 
population is summarized in Table 2. 
Specific to the biomarkers, it is evident that those workers in wet production were 
more likely to have a MDI-specific IgG ≥ 1:20 titer (Table 3).  A fewer percentage of 
administrative workers were found to have total IgE > 100.  
Analysis of MDI-IgG Conversion: Negative to Positive 
 
A subgroup of 161 workers who was MDI-IgG negative in their first test was 
analyzed to examine time they became positive (titer ≥1:20).  Examination of the Kaplan 
Meier curve (Figure 1) for the time required for MDI-IgG to convert from negative to 
positive demonstrates that at day number 1096 (3 years), 35.8% had converted in wet 
production (X, where n = 97) compared to 15.5% in dry production (Y, where n = 38), 
and 8.2%  in administrative jobs (Z, where n = 26).  The Kaplan Meier Log-Rank Test 
indicates a statistically significant difference in the survival curves (p = 0.0076). 
Next, a Cox Proportional Hazard model was performed in order to examine for 
covariates.  With respect to the conversion of MDI-IgG from negative to positive, the 
following variables were statistically significant: job class (wet production versus dry 
production), history of asthma, current smoking, presence of shortness of breath (SOB), 
and use of personal protective equipment (PPE). 
This model provides estimates for the hazard function hi(t) = Ci × h(t): 
   (  )                   
Model estimates with p-values and corresponding hazard ratios are included in Table 4. 
When looking at these variables graphically (Figure 1), the conversion from 
negative to positive IgG clearly occurs more rapidly in the group of wet production jobs.  
It is of note that the estimate involving the difference between administrative jobs and 
wet production jobs is not significant.  This is likely due to the small number of data 
points associated with administrative jobs (n = 26), leading to a large standard error (SE 
= 1.03).  On the other hand, there is a significantly lower hazard associated with dry 
production than wet production tasks.  The hazard of converting from negative to positive 
MDI-IgG of an employee in dry production is only one quarter that of an employee 
working in wet production.   
The data also demonstrate that a history of asthma and current smoking increased 
the hazard of MDI-IgG conversion, whereas use of personal protective equipment is 
protective of this conversion.  Interestingly, shortness of breath is also statistically 
significantly protective of the MDI-IgG conversion from negative to positive. 
Analysis of IgG Conversion: Positive to Negative 
 
MDI-IgG conversion was then examined for 85 participants who had a positive 
test and at least one more test.  The Kaplan Meier curve (Figure 2) examined for time 
required for MDI specific-IgG to convert from positive to negative demonstrates that at 
day number 1096 (3 years), 55.4% converted in wet production (X, n = 66) whereas 
42.7% converted in dry production (Y, n = 16) and 50.0% converted in administrative 
jobs (Z, n = 3).  A Kaplan Meier survival analysis evaluated using the Log-Rank Test 
indicates that without adjusting for covariates, there is no significant difference by job in 
time for an individual to convert from positive to negative MDI-specific IgG (p = 
0.9232). 
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Similarly to the analysis of MDI-specific IgG conversion from negative to 
positive, subjects whose specific IgG converted from positive to negative were selected. 
Next, a Cox Proportional Hazard regression model was applied to adjust for covariates. 
The only variable determined to be statistically significant was the use of personal 
protective equipment. 
In this case, the model provides the following estimate of the hazard function: 
  ( )   
        ( ) 
In this case, β1 = 1.19 with standard error 0.53 (p = 0.026).  The hazard ratio is 3.28, 
which means that using personal protective equipment provides a more than three-fold 
increase in the likelihood of IgG converting from positive to negative. 
Comparison of 2012 and 2013 
At a later stage in the process of analysis, serology data from 2013 became 
available.  Although these data were not able to be included in the core data set, they 
were briefly examined to have a basis of comparison.  Several safety and intervention 
programs were implemented in 2013, and the changes in MDI-IgG levels were studied.  
Interventions included greater use of gloves, protective clothing and respirators.  In order 
to accomplish this, the 2013 data were matched directly to the 2012 data.  A sign test was 
used to evaluate the paired serology results for individuals between 2012 and 2013.  A 
significant decrease was demonstrated between the 2012 and 2013 data (p = 0.0001).   
2013 Worker Safety Survey 
The three-question survey completed by workers who participated in physicals in 
2013 provided information on perceived safety factors and accessibility to resources.  
Accordingly, 72.8% of the workers who participated in the annual exam and survey at the 
fabric-coating company felt that there was to some degree an improvement in workplace 
safety over the past year (Figure 3), but only 60.2% of workers felt at least somewhat safe 
at work (Figure 4).  82.3% of the workers felt at least somewhat likely to find the 
personal protective equipment that they needed to do their jobs (Figure 5). 
 
Discussion 
Overall Findings 
Serology studies of a workforce at a fabric-coating factory where MDI is used 
have revealed new insight into the kinetics of the development and resolution of MDI-
specific immune response among exposed workers and provided further evidence to 
support a role for biomonitoring.  Surveillance of immunologic biomarkers can offer both 
benefits for individual protection and target engineering improvements for the company 
as a whole. 
The data also suggest that MDI-specific serology could play an important role in 
preventing MDI asthma by serving as a biomarker of exposure, thus confirming effective 
hygiene and providing feedback on the effectiveness of PPE and engineering controls.  
These findings emphasize the need for surveillance and intervention in industry to 
support the safety of workers. 
MDI- Specific IgG Conversion from Negative to positive  
Our analysis of all eligible employees at the fabric coating company indicates that 
those in wet production are more likely to turn MDI-specific IgG positive at an earlier 
date than those in dry production.  Data are consistent with a higher potential for 
exposure among wet workers.
11
  Despite a distinct visual difference among job 
18 
 
classifications on the Kaplan Meir curve, analysis regarding exposure magnitude of 
administrative tasks versus wet production tasks demonstrates no statistically significant 
difference.  This is most likely due to a large standard error propagated by a small sample 
size in administration jobs. 
Modeling of the covariates allowed us to explore which characteristics of 
isocyanate exposure determined a risk for seroconversion.  Our data showed increased 
risk associated with previous diagnosis of asthma.  However, our analysis does not 
address when the asthma was first diagnosed, so we are unable to comment on whether 
the MDI-IgG relates to current (MDI) asthma or prior disease (childhood asthma).
28
  A 
history of smoking appeared to be associated with an increased risk of developing MDI-
specific IgG; however, neither high total IgE > 100 nor > 500 were found to be 
significant.  The possibility of an independent mechanism of IgE may explain why 
smoking and atopy are not exclusive determinants of asthma.
29
  As expected, wearing 
gloves, mask, or respirators provided a protective factor against individual immunologic 
conversion.
25
  
Contrary to our a priori assumptions, shortness of breath appeared to be protective 
for the development of MDI-specific IgG conversion.
30
  The explanation for this remains 
unclear, but one possibility is that those who are symptomatic with cardiac or respiratory 
conditions were more likely to be conscientious of staying away from exposure and 
wearing PPE, thereby decreasing exposure.  Alternatively, it is possible the finding may 
be artificial due to an imprecise definition of shortness of breath in patient questionnaire: 
neither etiology nor degree of severity was assessed within the database. 
This study confirms previous studies demonstrating that isocyanate specific-IgG 
antibodies appear to correlate with exposure.  Evaluation of immunologic response to a 
surrogate marker of exposure based on job classification may serve as confirmation that a 
dose-response relationship does exist and that immunologic conversion may be prevented 
with the appropriate interventions.
4
 
MDI- Specific IgG Conversion from Positive to Negative 
Conversion of MDI-IgG from a positive to negative immunologic response does 
not seem to be dependent on surrogate job classifications.  While interpretation of this 
factor has to be taken cautiously due to the scarcity of previous data to suggest the time 
interval needed for MDI- specific IgG to become undetectable, this finding may serve as 
the impetus for further research in this area.  Based on an annual surveillance model, it 
appears that conversion back to negative serological marker after being positive is not 
different among the job tasks, even when temporal contact and level of exposure remains 
constant. 
As previously seen in the first model (negative to positive specific-IgG 
conversion), after controlling for covariates, it appeared that wearing PPE was a 
significant protective factor.
25,31
  The use of PPE also afforded a three-fold increase in the 
likelihood of MDI-IgG converting from positive to negative.  While using PPE is the 
lowest on the hierarchy of controls due to compliance variability, this finding that PPE 
protects workers should underscore the importance of interventions in protecting workers 
exposed to isocyanates.
15,31
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Intervention Studies 
Preliminary data to determine workers perception of safety within the fabric coating plant 
was positive overall.  The majority of workers felt there was at least a measure of 
improvement in safety compared to previous years.  This correlated well with a 
comparison of exposure levels based on MDI- specific IgG tests of the 2012 and 2013 
data.  The data reveals a significant improvement between the 2012 and 2013 
immunologic results. 
It is our impression that interventions for other exposures and hazards during the 
course of the last year at this fabric-coating company has brought added attention to the 
need for overall safety interventions and may have contributed to the decline in the 
exposure biomarker (MDI-specific IgG).  The data strongly support the use of PPE as a 
protective factor in serologic conversion.  While this is not to assert that most PPE can 
eliminate isocyanate exposure—glove breakthroughs and contaminations certainly occur 
and masks may not be sufficient—simple maneuvers clearly decrease the risk.15,32 
Exposure elimination is one of the most strongly proven and the preferred primary 
preventive approach to reduce occupational asthma; however, since elimination is not 
always possible, exposure reduction is considered the second best option for primary 
prevention.
22
  While incomplete and still in transition, the fabric company employed a 
varied systematic approach to improving safety over the last year, including First 
Aid/CPR classes for supervisors, safety focus group discussions, and overt display of 
safety changes (including respirator use by some wet production workers, mandated static 
grounder requirements, and new safety hoods over production machines).  These changes 
may explain the recent decline in MDI-IgG markers. 
Limitations 
While not the initial intention, the most recent data from 2013 was not included in 
our core data set.  In retrospect, this omission may have provided a better assessment and 
overall reflection of the company prior to implementation of safety changes.  Multiple 
safety and intervention programs were being implemented in 2013, and inclusion of the 
2013 data may have affected the time to seroconversion.  The safety programs would be 
related to exposure and process changes and would obscure the true endpoints.  
Due to our rigid inclusion criteria, the database consisted of a total of 366 
individuals, but only 223 were accounted for in our analysis.  Most of the exclusion was 
due to limited number of data points (e.g. individuals who had only one previous test for 
the immunologic marker), which prohibited a longitudinal analysis.   
In principle, the use of questionnaires in studies may pose a selection bias 
determined by who chose to fill out the questionnaire; however, this was not the case in 
our study.  These questionnaires were completed as part of a health assessment survey for 
annual surveillance exams. While not every question was complete (two individuals had 
missing date of birth), the surveys were integrated into the annual exams and were 
completed by all workers that had annual physicals.  
Because data were only collected once a year, it is possible that this annual 
serology is not entirely reflective of the actual daily or weekly trend related to exposure.  
As outlined previously, this may have led to concluding insignificant relationships in the 
data where a significant relationship truly exists.  As there are minimal studies looking at 
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longitudinal biomarkers, the findings in this study are novel and should serve to motivate 
and spur future studies. 
The study was unable to account for individual time since last exposure and 
nature of the exposures.  Additionally, the study was unable to sort out the impact of 
individual components in the interventions.  We believe the surrogate job classifications 
identified by the industrial hygienist accounted for the nature of exposures.  This study 
was not intended to be a series of case-reports, but rather an epidemiological overview on 
the sample population.  The goal was to determine the overall risk characteristics 
associated with seroconversion of IgG. 
Summary 
Longitudinal data was available from annual surveillance conducted on a cohort 
of workers from a polyurethane fabric-coating company.  Previous data reflected that by 
using MDI- albumin assays, MDI-IgG titers could be used to monitor exposure among 
workers.  Long-term follow up is needed to identify the potential association of 
developing immunologic response and the corresponding sequelae (e.g. asthma).  Our 
study confirmed that the use of MDI-specific IgG biomarkers can predict level of 
occupational exposure to MDI.  Using the specific IgG biomarkers has allowed for 
insights into understanding dose-dependent exposure and risk.  We also note that trend 
changes to IgG levels can be altered by occupational safety interventions.  A preliminary 
study among workers revealed that effective workplace intervention decreased exposure 
and subsequently MDI IgG titer level.  Further study is needed to determine whether 
decreasing exposure eventually leads to improved overall health of workers. 
 
 
References 
 
1. Redlich CA, Stowe MH, Wisnewski AV, Eisen EA, Karol MH, Lemus R, Holm 
CT, Chung JS, Sparer J, Liu Y and others. Subclinical immunologic and 
physiologic responses in hexamethylene diisocyanate-exposed auto body shop 
workers. Am J Ind Med 2001;39(6):587-97. 
2. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333(2):107-
12. 
3. Creely KS, Hughson GW, Cocker J, Jones K. Assessing Isocyanate Exposures in 
Polyurethane Industry Sectors Using Biological and Air Monitoring Methods. 
Annals of Occupational Hygiene 2006;50(6):609-621. 
4. Bello D, Herrick CA, Smith TJ, Woskie SR, Streicher RP, Cullen MR, Liu Y, 
Redlich CA. Skin exposure to isocyanates: reasons for concern. Environ Health 
Perspect 2007;115(3):328-35. 
5. Tarlo SM, Liss GM. Diisocyanate-induced asthma: diagnosis, prognosis, and 
effects of medical surveillance measures. Appl Occup Environ Hyg 
2002;17(12):902-8. 
6. Desai VM. Water Resistant-Breathable Hydrophilic Polyurethane Coatings. 
Journal of industrial textiles 1995;25(1):39. 
7. Redlich CA, Cain H, Wisnewski AV. The immunology and prevention of 
isocyanate asthma: A model for low molecular weight asthma. 2008. Copyright© 
1999 by Thieme Medical Publishers, Inc. p 591-599. 
8. Chester DA, Hanna EA, Pickelman BG, Rosenman KD. Asthma death after 
spraying polyurethane truck bedliner. Am J Ind Med 2005;48(1):78-84. 
9. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J 
Respir Crit Care Med 2005;172(3):280-305. 
10. Streicher RP, Reh CM, Key-Schwartz RJ, Schlecht PC, Cassinelli ME, O'Connor 
PF. Determination of airborne isocyanate exposure: considerations in method 
selection. AIHAJ-American Industrial Hygiene Association 2000;61(4):544-556. 
11. Wisnewski AV, Stowe MH, Nerlinger A, Opare-Addo P, Decamp D, Kleinsmith 
CR, Redlich CA. Biomonitoring Hexamethylene diisocyanate (HDI) exposure 
based on serum levels of HDI-specific IgG. Ann Occup Hyg 2012;56(8):901-10. 
12. Carino M. Death due to asthma at workplace in a diphenylmethane diisocyanate-
sensitized subject. Respiration;64(1):111. 
13. Hamada H, Isaksson M, Bruze M, Engfeldt M, Liljelind I, Axelsson S, Jonsson B, 
Tinnerberg H, Zimerson E. Dermal uptake study with 4,4'-diphenylmethane 
diisocyanate led to active sensitization. Contact Dermatitis 2012;66(2):101-5. 
14. Bello D, Woskie SR, Streicher RP, Liu Y, Stowe MH, Eisen EA, Ellenbecker MJ, 
Sparer J, Youngs F, Cullen MR and others. Polyisocyanates in occupational 
environments: a critical review of exposure limits and metrics. Am J Ind Med 
2004;46(5):480-91. 
15. Bello D, Sparer J, Redlich CA, Ibrahim K, Stowe MH, Liu Y. Slow curing of 
aliphatic polyisocyanate paints in automotive refinishing: a potential source for 
skin exposure. J Occup Environ Hyg 2007;4(6):406-11. 
24 
 
16. Vandenplas O, Malo JL, Saetta M, Mapp CE, Fabbri LM. Occupational asthma 
and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J 
Ind Med 1993;50(3):213-28. 
17. Mapp CE, Balboni A, Baricordi R, Fabbri LM. Human leukocyte antigen 
associations in occupational asthma induced by isocyanates. Am J Respir Crit 
Care Med 1997;156(4 Pt 2):S139-43. 
18. Aalto-Korte K, Suuronen K, Kuuliala O, Henriks-Eckerman ML, Jolanki R. 
Occupational contact allergy to monomeric isocyanates. Contact Dermatitis 
2012;67(2):78-88. 
19. Wisnewski AV, Liu J, Redlich CA. Antigenic changes in human albumin caused 
by reactivity with the occupational allergen diphenylmethane diisocyanate. Anal 
Biochem 2010;400(2):251-8. 
20. Pisati G, Baruffini A, Bernabeo F, Cerri S, Mangili A. Rechallenging subjects 
with occupational asthma due to toluene diisocyanate (TDI), after long-term 
removal from exposure. Int Arch Occup Environ Health 2007;80(4):298-305. 
21. Sparer J, Stowe MH, Bello D, Liu Y, Gore RJ, Youngs F, Cullen MR, Redlich 
CA, Woskie SR. Isocyanate exposures in autobody shop work: the SPRAY study. 
J Occup Environ Hyg 2004;1(9):570-81. 
22. Heederik D, Henneberger PK, Redlich CA. Primary prevention: exposure 
reduction, skin exposure and respiratory protection. Eur Respir Rev 
2012;21(124):112-24. 
23. Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. Asthma-like 
symptoms in wood product plant workers exposed to methylene diphenyl 
diisocyanate. Chest 2000;118(4):1183-93. 
24. Redlich CA, Herrick CA. Lung/skin connections in occupational lung disease. 
Curr Opin Allergy Clin Immunol 2008;8(2):115-9. 
25. Pronk A, Preller L, Raulf-Heimsoth M, Jonkers IC, Lammers JW, Wouters IM, 
Doekes G, Wisnewski AV, Heederik D. Respiratory symptoms, sensitization, and 
exposure response relationships in spray painters exposed to isocyanates. Am J 
Respir Crit Care Med 2007;176(11):1090-7. 
26. Paul JR. Serological epidemiology and the function of serum banks. Archives of 
virology 1965;17(3-4):465. 
27. Campo P, Wisnewski AV, Lummus Z, Cartier A, Malo JL, Boulet LP, Bernstein 
DI. Diisocyanate conjugate and immunoassay characteristics influence detection 
of specific antibodies in HDI-exposed workers. Clin Exp Allergy 
2007;37(7):1095-102. 
28. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA. 
Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 
2004;113(6):1178-84. 
29. Chan-Yeung M, Malo J-L. Occupational Asthma. New England Journal of 
Medicine 1995;333(2):107-112. 
30. Sari-Minodier I, Charpin D, Signouret M, Poyen D, Vervloet D. Prevalence of 
self-reported respiratory symptoms in workers exposed to isocyanates. Journal of 
occupational and environmental medicine 1999;41(7):582-588. 
31. Gannon PF, Berg A, Gayosso R, Henderson B, Sax S, Willems H. Occupational 
asthma prevention and management in industry—an example of a global 
programme. Occupational Medicine 2005;55(8):600-605. 
32. Liu Y, Sparer J, Woskie SR, Cullen MR, Chung JS, Holm CT, Redlich CA. 
Qualitative assessment of isocyanate skin exposure in auto body shops: a pilot 
study. Am J Ind Med 2000;37(3):265-74. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
 
 
 
 
 
 
 
Appendix A: TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A-1: 
 
 
 
 
Table 1: Exposure Groups based on job title/task 
  
Exposure Group Job Title/Task 
Wet Production Machine operators/helpers, mixing shed workers, 
maintenance, hazardous waste workers, production floor 
supervisors 
Dry Production Quality control, trimming, inspector, slitter, custodial, 
laboratory workers 
Administrative Office, sales, clerical, shipping receiving. 
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Table 2: Characteristics of the Population 
 
 Tot. Freq. Tot. % Wet Prod. % 
(n=144) 
Dry Prod. % 
(n=48) 
Admin. % 
(n=29) 
Race/Ethnicity      
Hispanic 127 57.0 70.8 37.5 20.7 
Asian 8 3.6 0.7 8.3 6.9 
Black 36 16.1 15.3 29.2 0.0 
White 47 21.1 11.1 20.8 72.4 
Other 5 2.2 2.1 4.2 0.0 
      
Age Class      
≤ 25 years old 26 11.8 13.9 8.3 6.9 
> 25 – 35 65 29.4 30.6 25.0 31.0 
> 35 – 45 64 28.9 29.2 29.2 27.6 
> 45 – 55 51 23.1 20.8 25.0 31.0 
> 55 – 65 15 6.8 5.6 12.5 3.5 
      
Gender      
Female 27 12.1 2.1 18.8 51.7 
Male 196 87.9 97.9 81.3 48.3 
      
Characteristics      
Current Smoker 66 30.8 33.3 34.0 11.5 
History of Smoking 118 55.4 63.1 50.0 23.1 
Asthma (including 
childhood) 
46 21.5 20.6 29.8 11.5 
Allergies 72 33.6 31.9 31.9 46.2 
Rash 22 10.3 13.6 6.4 0.0 
Shortness of Breath 40 18.8 17.9 21.3 19.2 
Use of PPE 181 93.8 97.8 88.6 71.4 
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Table 3: Biomarkers based on exposure classification  
 
Exposure 
Classification 
Total IgE > 100 Total IgE > 500 + Specific IgG 
Freq % Freq % Freq % 
Wet Production 49 34.0 7 4.9 82 56.9 
Dry Production 16 33.3 4 8.3 16 33.3 
Administrative 6 20.7 0 0.0 5 17.2 
Total 71 32.1 11 5.0 103 46.6 
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Appendix A-4 
 
 
 
Table 4: Analysis of Estimates for IgG Conversion from Negative to Positive 
 
Variable Estimate (βi) Std Error P-Value Hazard Ratio 
1. Administrative 
     (vs. Wet Production) 
-1.39 1.03 0.180 0.25 
2. Dry Production 
     (vs. Wet Production) 
-1.45 0.49 0.003 0.24 
3. Asthma -0.81 0.39 0.040 0.45 
4. Smoking -0.68 0.34 0.044 0.51 
5. SOB 1.81 0.76 0.017 6.10 
6. PPE 1.57 0.53 0.003 4.80 
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Appendix B-1 
 
 
 
 
Figure 1:MDI-IgG Conversion from Negative to Positive by exposure classification 
 
(Job “X” = Wet Production; Job “Y” = Dry Production; Job “Z” = Administrative) 
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Figure 2: MDI-IgG Conversion from Positive to Negative by exposure classification 
 
(Job “X” = Wet Production; Job “Y” = Dry Production; Job “Z” = Administrative) 
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Figure 3: Survey on workplace safety question 1 
 
 
 
 
Figure 4: Survey on workplace safety question 2 
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 Figure 5: Survey on workplace safety question 3 
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